Download
s00393-020-00877-1.pdf 368,42KB
WeightNameValue
1000 Titel
  • Ist komplette Immunität gegen Masern bei Patienten mit rheumatischen Erkrankungen ein realistisches Ziel, und wie ist es möglicherweise zu erreichen?
1000 Titelzusatz
  • Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?
1000 Autor/in
  1. Braun, J. |
  2. Kiltz, U. |
  3. Müller-Ladner, U. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-09-18
1000 Erschienen in
1000 Quellenangabe
  • 79(9):922-928
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00393-020-00877-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647971/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Measles outbreaks occur rather frequently in Germany. Patients with chronic inflammatory diseases are often treated with immunosuppressants. A recent study showed that about 7% of such patients are not protected against measles according to the lack of documentation in the vaccination card or the absence of protective antibodies. The Standing Committee on Immunization (STIKO) recommends a first vaccination against measles as a measles-mumps-rubella combined vaccination (MMR) in children aged 11-14 months and a second vaccination at 14-23 months. For adults born after 1970, vaccination against measles is recommended if they have not yet been vaccinated against measles or have only been vaccinated once against measles or if their vaccination status is unclear. In April 2019, STIKO published instructions for vaccinations recommended for immunodeficiency. Since March 1, 2020, measles vaccination have been compulsory in Germany.
1000 Sacherschließung
lokal Measles/immunology [MeSH]
lokal Vaccination card
lokal Impfausweis
lokal Infant [MeSH]
lokal Antibodies, Viral [MeSH]
lokal Measles protection act
lokal Immunsuppression
lokal Rheumatic Diseases/immunology [MeSH]
lokal Child [MeSH]
lokal Mumps/immunology [MeSH]
lokal Measles/prevention
lokal Mumps/prevention
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Rubella/immunology [MeSH]
lokal Antivirale Antikörper
lokal Vaccination
lokal Immunosuppression
lokal Impfung
lokal Standpunkte
lokal Germany [MeSH]
lokal Anti-viral antibodies
lokal Rubella/prevention
lokal Vaccination [MeSH]
lokal Masernschutzgesetz
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QnJhdW4sIEou|https://frl.publisso.de/adhoc/uri/S2lsdHosIFUu|https://frl.publisso.de/adhoc/uri/TcO8bGxlci1MYWRuZXIsIFUu
1000 Hinweis
  • DeepGreen-ID: 19a6734b1fa143a1bfad7051cf572950 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6470056.rdf
1000 Erstellt am 2023-11-18T03:34:13.383+0100
1000 Erstellt von 322
1000 beschreibt frl:6470056
1000 Zuletzt bearbeitet 2023-12-01T11:04:12.345+0100
1000 Objekt bearb. Fri Dec 01 11:04:12 CET 2023
1000 Vgl. frl:6470056
1000 Oai Id
  1. oai:frl.publisso.de:frl:6470056 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source